• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

MECHANISTIC STUDY OF THE ROLE OF TYROSINE KINASE SIGNAL

Research Project

Project/Area Number 12670427
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内科学一般
Research InstitutionKYUSHU UNIVERSITY

Principal Investigator

NAKANO Shuji  KYUSHU UNIVERSITY HOSPITAL., FACULTY OF MEDICINE, ASSISTANT PROF., 医学部・附属病院, 講師 (40164248)

Co-Investigator(Kenkyū-buntansha) MITSUGI Kenji  KYUSHU UNIV., FAC. MED., INSTRUCTOR, 医学部・附属病院, 助手 (20315063)
NAKAMURA Minoryu  KYUSHU UNIV., FAC. MED., INSTRUCTOR, 医学部・附属病院, 助手 (40217906)
Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2001: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2000: ¥2,200,000 (Direct Cost: ¥2,200,000)
KeywordsTyrosine kinase / apoptosis / signal transduction / Drug resistance / Rac / Rho / invasion / Src / Ras / 足場依存性喪失 / Srcがん遺伝子
Research Abstract

Activation of Src and Ras has been demonstrated be closely associated with the pathogenesis and metastatic potential of many human tumors. However, the role of these oneogenes in the drug sensitivity and invasion process remain to be clarified. We examined the role of Src and Ras on these processes, using HAG-1 human epithelial cell lines transfected with v-src and activated H-ras. First we examined the potential role of Ras and Rac, a small GTPase binding protein which acts downstream of Ras, by introducing adenoviral vector containing dominant negative Ras and Rac (DN/Ras and DN/Rac) into these cells. Both DN/Ras and DN/Rac reduced the invasive potential of src-transfected cells. Moreover, DN/Rac suppressed completely the tumorigenic potentials of src-transfected cells in nude mice. These results suggest that Src, Ras, Rac, all appeared to participate in the invasion processes, and that Rac may act downstream of these signaling pathways of invasion and tumorigenicity. Next we have ex … More amined the effect of activated Src on the sensitivity to taxotere, an anticancer drug targeting microtubules. As compared with parental HAG-1 cell line, v-src-transfected HAG/src3-l cells became 7.0-fold sensitive to taxotere. The taxotere sensitivity in HAG/src3-1 cells was reversed by herbimycin A (HA), indicating that Src tyrosine kinase augments sensitivity to taxotere. Treatment of HAG/src3-1 cells with taxotere resulted in phosphorylation of Bel-2 and subsequent induction of apoptotic cell death, whereas neither Bcl-2 phosphorylation nor apoptosis occurred in parental or c-H-ras-transfected HAG-1 cells. The Bcl-2 protein is overexpressed in v-src-transfected cell line. Treatment of HAG/src3-1 cells with HA reduced the expression and phosphorylation of Bcl-2, and abrogated taxotere-induced apoptosis, suggesting a potential role for Src tyrosine kinase in the taxotere-induced apoptotic events. H-7, and wortmannin, PI-3 kinaseinhibitor, neither altered taxoteresensitivity nor inhibited taxotere-induced apoptosis in these cells. These data indicate that the ability of activated Src to increase taxotere sensitivity would be mediated by apoptotic events occurring through Src to downstream signal transduction pathways toward Bcl-2 phosphorylation, but not by activated Ras, PI-3 kinase or protein kinase C. Less

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (18 results)

All Other

All Publications (18 results)

  • [Publications] Tokumitsu Y: "Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras"Journal of Cellular Physiology. 183. 221-227 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Kato K: "Structure and functional analysis of the human STAT3 gene promoter : alteration of chromatin structure as a possible mechanism for the upregulation in cisplatin-resistant cells"Biochim Biophys Acta. 1493. 91-100 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Koizumi W: "Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer"Oncology. 58. 191-197 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sawabe T: "Defect of lck in a patient with common variable immunodeficiency"International J. Molecular Medicine. 7. 609-614 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Boudny V: "Src tyrosine kinase induces taxotere sensitivity through phosphorylation of Bcl-2 and apoptosis in human gallbladder adenocarcinoma cells"British J. Cancer. 86. 463-469 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] 中野修治: "分子がん治療 シグナル伝達からみたがんの分子機構と治療への応用"先端医学社. 10 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tokumitsu Y., Nakano, S., Ueno H., Niho Y.: "Suppression of malignant growth potentials of v-src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras"J. Cell. Physiology. 183. 221-227 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Koizumi W., Kurihara M., Nakano S., Hasegawa K.: "Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouraeil, in Advanced Gastric Cancer"Oncology. 58 (3). 191-197 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Kato K., Nomoto M., Izumi H., Nakano S., Niho Y. Kohno K.: "Structure and functional analysis of the human STAT3 gene promoter: alteration of chromatin struciure as a possible mechanism for the upregulation in cisplatin-resisiam cell"Biochim. Biophys. Acta. 1493. 91-100 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sawabe T., Horiuchi T., Nakamura M., Tsukamoto H., Nakahara T., Harashima SI., Tsuchiya T., Nakano S.: "Defect of lck in aient with common variable immunodeficiency"Int. J. Mol. Med.. 7 (6). 609-614 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Boudny V., Nakano S.: "Src tyrosine kinase augments taxotcre-induced apoptosis through enhanced expression and phosphorylation of Bcl-2"Br. J. Cancer. 86. 463-469 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sawabe T: "Defect of lck in a patient with common variable immunodeficiency"International J. Molecular Medicine. 7. 609-614 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Boudny V: "Src tyrosine kinase induces taxotere sensitivity through phosphorylation of Bcl-2 and apoptosis in human gallbladder adenocarcinoma cells"British J. Cancer. 183(in press). (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] 中野修治: "がん治療のあゆみ"がん集学的治療研究財団. 8 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Koizumi W: "Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer"Oncology. 58. 191-197 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Tokumitsu Y: "Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras"Journal of Cellular Physiology. 183. 221-227 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Kato K: "Structure and functional analysis of the human STAT3 gene promoter : alteration of chromatin structure as a possible mechanism for the upregulation in cisplatin-resistant cells"Biochim Biophys Acta. 1493. 91-100 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 中野修治: "分子がん治療 シグナル伝達からみたがんの分子機構と治療への応用"先端医学社. 10 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi